(3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide

C44H43F3N8O5S — CID 163864783

IUPAC(3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide
SMILESC=C1CCC(N2Cc3cc(CCN4CCN(c5ccc(-c6cnc7[nH]cc(C(=O)c8c(F)ccc(NS(=O)(=O)N9CC[C@@H](F)C9)c8F)c7c6)cc5)CC4)ccc3C2=O)C(=O)N1
InChIInChI=1S/C44H43F3N8O5S/c1-26-2-11-38(43(57)50-26)55-24-30-20-27(3-8-33(30)44(55)58)12-14-52-16-18-53(19-17-52)32-6-4-28(5-7-32)29-21-34-35(23-49-42(34)48-22-29)41(56)39-36(46)9-10-37(40(39)47)51-61(59,60)54-15-13-31(45)25-54/h3-10,20-23,31,38,51H,1-2,11-19,24-25H2,(H,48,49)(H,50,57)/t31-,38?/m1/s1
InChIKeyFJJZQWOBECNPEM-LERZKORDSA-N
MW852.94 g/mol
LogP5.55
Rot. Bonds11

About (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide

(3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide (PubChem CID 163864783) has the molecular formula C44H43F3N8O5S and a molecular weight of 852.94 g/mol. Its IUPAC name is (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide.

Molecular Properties

Compound Name(3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide
PubChem CID163864783
Molecular FormulaC44H43F3N8O5S
Molecular Weight852.94 g/mol
Exact Mass852.30
IUPAC Name(3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide
SMILESC=C1CCC(N2Cc3cc(CCN4CCN(c5ccc(-c6cnc7[nH]cc(C(=O)c8c(F)ccc(NS(=O)(=O)N9CC[C@@H](F)C9)c8F)c7c6)cc5)CC4)ccc3C2=O)C(=O)N1
InChIInChI=1S/C44H43F3N8O5S/c1-26-2-11-38(43(57)50-26)55-24-30-20-27(3-8-33(30)44(55)58)12-14-52-16-18-53(19-17-52)32-6-4-28(5-7-32)29-21-34-35(23-49-42(34)48-22-29)41(56)39-36(46)9-10-37(40(39)47)51-61(59,60)54-15-13-31(45)25-54/h3-10,20-23,31,38,51H,1-2,11-19,24-25H2,(H,48,49)(H,50,57)/t31-,38?/m1/s1
InChIKeyFJJZQWOBECNPEM-LERZKORDSA-N
XLogP5.55
TPSA151.05 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds11
Heavy Atoms61
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500852.94
LogP ≤ 55.55
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide?
The IUPAC name of (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide (CID 163864783) is (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide.
What is the SMILES notation for (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide?
The canonical SMILES for (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide is C=C1CCC(N2Cc3cc(CCN4CCN(c5ccc(-c6cnc7[nH]cc(C(=O)c8c(F)ccc(NS(=O)(=O)N9CC[C@@H](F)C9)c8F)c7c6)cc5)CC4)ccc3C2=O)C(=O)N1.
What is the InChIKey of (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide?
The InChIKey is FJJZQWOBECNPEM-LERZKORDSA-N. The full InChI is InChI=1S/C44H43F3N8O5S/c1-26-2-11-38(43(57)50-26)55-24-30-20-27(3-8-33(30)44(55)58)12-14-52-16-18-53(19-17-52)32-6-4-28(5-7-32)29-21-34-35(23-49-42(34)48-22-29)41(56)39-36(46)9-10-37(40(39)47)51-61(59,60)54-15-13-31(45)25-54/h3-10,20-23,31,38,51H,1-2,11-19,24-25H2,(H,48,49)(H,50,57)/t31-,38?/m1/s1.
What are the key properties of (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide?
(3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide has a molecular weight of 852.94 g/mol, XLogP of 5.55, 11 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-N-[2,4-difluoro-3-[5-[4-[4-[2-[2-(6-methylidene-2-oxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]ethyl]piperazin-1-yl]phenyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]phenyl]-3-fluoropyrrolidine-1-sulfonamide is sourced from PubChem (CID 163864783), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).